MATSUMOTO Akihiro
Shinshu University Hospital Clinical Center for Viral Hepatitis
Professor
Researcher Information
Research activity information
Paper
- Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B
Matsumoto A, Nishiguchi S, Enomoto H, Tanaka Y, Shinkai N, Okuse C, Kang JH, Matsui T, Miyase S, Yatsuhashi H, Nagaoka S, Kanda T, Enomoto M, Yamada R, Hiramatsu N, Saito S, Takaguchi K, Ito K, Masaki T, Morihara D, Tsuge M, Chayama K, Ikeda F, Kagawa T, Kondo Y, Murata K, Tanaka E
J Gastroenterol, Jul. 2020
Lead - Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus
Fujimori N, Tanaka N, Kimura T, Sano K, Horiuchi A, Kato N, Takahashi Y, Kuribayashi N, Sugiura A, Yamazaki T, Joshita S, Umemura T, Matsumoto A, Tanaka E
Clin J Gastroenterol, 13(1), 83-89, Feb. 2020 - 長期経過加療中の非肝硬変期に肝細胞癌を合併した原発性胆汁性胆管炎の２例
杉浦亜弓, 城下智, 山下裕騎, 木村岳史, 山崎智生, 藤森尚之, 小松通治, 松本晶博, 小林翔太, 梅村武司, 田中榮司
信州医学雑誌, 66(1), 39-49, 10 Feb. 2018
- A screening method with lymphocyte percentage and proportion of granular lymphocytes in the peripheral blood for large granular lymphocyte (LGL) leukemia.
Tanahashi T, Sekiguchi N, Matsuda K, Matsumoto A, Ito T, Nakazawa H, Ishida F
Int J Hematol, 105(1), 87-91, Jan. 2017
- Hepatitis B core-related antigen: a strong indicator for cessation of nucleos(t)ide analog therapy in patients with chronic hepatitis B.
Matsumoto A
J Gastroenterol, 52(1), 127-128, Jan. 2017 - Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis.
Umemura T, Sekiguchi T, Joshita S, Yamazaki T, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Shums Z, Norman GL, Tanaka E, Ota M
Liver Int, in press, Nov. 2016 - Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.
Murata K, Asano M, Matsumoto A, Sugiyama M, Nishida N, Tanaka E, Inoue T, Sakamoto M, Enomoto N, Shirasaki T, Honda M, Kaneko S, Gatanaga H, Oka S, Kawamura YI, Dohi T, Shuno Y, Yano H, Mizokami M
Gut, in press, Oct. 2016 - Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations.
Mori KI, Matsumoto A, Maki N, Ichikawa Y, Tanaka E, Yagi S
BMC Microbiol, 16(1), 224, Sep. 2016 - Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis.
Fujimori N, Tanaka N, Shibata S, Sano K, Yamazaki T, Sekiguchi T, Kitabatake H, Ichikawa Y, Kimura T, Komatsu M, Umemura T, Matsumoto A, Tanaka E
Hepatol Res, 46(10), 1019-27, Sep. 2016 - Autoimmune Pancreatitis Can Transform Into Chronic Features Similar to Advanced Chronic Pancreatitis With Functional Insufficiency Following Severe Calcification.
Kanai K, Maruyama M, Kameko F, Kawasaki K, Asano J, Oguchi T, Watanabe T, Ito T, Muraki T, Hamano H, Matsumoto A, Arakura N, Kawa S
Pancreas, 45(8), 1189-95, Sep. 2016 - Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan.
Yoshizawa K, Joshita S, Matsumoto A, Umemura T, Tanaka E, Morita S, Maejima T, Ota M
Hepatol Res, 46(9), 878-83, Aug. 2016 - Liver stiffness-spleen size-to-platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C.
Shibata S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E
Hepatol Res, 46(9), 884-9, Aug. 2016 - Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody.
Matsumoto A, Imaizumi M, Tanaka Y, Nishiguchi S, Yatsuhashi H, Ishida T, Moriyama K, Aoyagi K, Tanaka E
J Gastroenterol, in press, Jul. 2016 - Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease.
Shibata S, Joshita S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Komatsu M, Matsumoto A, Tanaka E
Springerplus, 5(1), 998, Jul. 2016 - Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.
Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E
Hepatol Res, in press, Jun. 2016 - Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Ichikawa Y, Joshita S, Umemura T, Shobugawa Y, Usami Y, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Tanaka E
Hepatol Res, in press, Mar. 2016 - Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B.
Matsumoto A, Yatsuhashi H, Nagaoka S, Suzuki Y, Hosaka T, Tsuge M, Chayama K, Kanda T, Yokosuka O, Nishiguchi S, Saito M, Miyase S, Kang JH, Shinkai N, Tanaka Y, Umemura T, Tanaka E
Hepatol Res, 45(12), 1195-202, Dec. 2015 - Clinicopathological characterisation of duodenal adenocarcinoma with high CD44 variant 9 expression.
Maruyama Y, Uehara T, Daikuhara S, Kobayashi Y, Nakajima T, Matsumoto A, Tanaka E, Ota H
PATHOLOGY, 47(7), 647-52, Dec. 2015 - Association Between Immunoglobulin G4-related Disease and Malignancy within 12 Years after Diagnosis: An Analysis after Longterm Followup.
Asano J, Watanabe T, Oguchi T, Kanai K, Maruyama M, Ito T, Muraki T, Hamano H, Arakura N, Matsumoto A, Kawa S
J Rheumatol, 42(11), 2135-42, Nov. 2015 - Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis.
Umemura T, Shibata S, Sekiguchi T, Kitabatake H, Nozawa Y, Okuhara S, Kimura T, Morita S, Komatsu M, Matsumoto A, Tanaka E
Hepatol Res, 45(7), 739-44, Jul. 2015 - Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis.
Sekiguchi T, Umemura T, Fujimori N, Shibata S, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E, Ota M
PLOS ONE, 10(6), e0131658, Jun. 2015 - Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis.
Umemura T, Joshita S, Sekiguchi T, Usami Y, Shibata S, Kimura T, Komatsu M, Matsumoto A, Ota M, Tanaka E
Am J Gastroenterol, 110(6), 857-64, Jun. 2015 - Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.
Komatsu M, Kimura T, Yazaki M, Tanaka N, Yang Y, Nakajima T, Horiuchi A, Fang ZZ, Joshita S, Matsumoto A, Umemura T, Tanaka E, Gonzalez FJ, Ikeda S, Aoyama T
Biochim Biophys Acta, 1852(3), 473-81, Mar. 2015 - Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
Kamijo N, Matsumoto A, Umemura T, Shibata S, Ichikawa Y, Kimura T, Komatsu M, Tanaka E
World J Gastroenterol, 21(2), 541-8, Jan. 2015 - Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan
Umemura, T; Katsuyama, Y; Yoshizawa, K; Kimura, T; Joshita, S; Komatsu, M; Matsumoto, A; Tanaka, E; Ota, M
PLOS ONE, 9(6), e100565, Jun. 2014
- Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B
Tanaka, E; Matsumoto, A
HEPATOLOGY RESEARCH, 44(1), 1-8, Jan. 2014 - STAT4 Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis
Joshita, S; Umemura, T; Nakamura, M; Katsuyama, Y; Shibata, S; Kimura, T; Morita, S; Komatsu, M; Matsumoto, A; Yoshizawa, K; Ishibashi, H; Tanaka, E; Ota, M
DISEASE MARKERS, 2014, 727393, 2014 - 【IgG4と肝胆膵】 既知の肝胆膵疾患との関連性 慢性膵炎とIgG4関連病態 自己免疫性膵炎は慢性膵炎に移行しうる
丸山 真弘, 新倉 則和, 尾崎 弥生, 渡邉 貴之, 伊藤 哲也, 金井 圭太, 小口 貴也, 村木 崇, 浜野 英明, 松本 晶博, 川 茂幸
肝・胆・膵, 67(3), 399-407, Sep. 2013 - 【自己免疫性膵炎の最前線】 自己免疫性膵炎と膵石症
丸山 真弘, 新倉 則和, 尾崎 弥生, 渡邉 貴之, 伊藤 哲也, 金井 圭太, 小口 貴也, 村木 崇, 浜野 英明, 松本 晶博, 川 茂幸
胆と膵, 34(9), 737-744, Sep. 2013 - Comparison of carbon dioxide and air insufflation use by non-expert endoscopists during endoscopic retrograde cholangiopancreatography
Muraki, T; Arakura, N; Kodama, R; Yoneda, S; Maruyama, M; Itou, T; Watanabe, T; Maruyama, M; Matsumoto, A; Kawa, S; Tanaka, E
DIGESTIVE ENDOSCOPY, 25(2), 189-196, Mar. 2013 - Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis
Morita, S; Joshita, S; Umemura, T; Katsuyama, Y; Kimura, T; Komatsu, M; Matsumoto, A; Yoshizawa, K; Kamijo, A; Yamamura, N; Tanaka, E; Ota, M
Hum Immunol, 74(2), 219-222, Feb. 2013 - Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long-term follow-up study of 73 Japanese patients
Maruyama M, Arakura N, Ozaki Y, Watanabe T, Ito T, Yoneda S, Maruyama M, Muraki T, Hamano H, Matsumoto A, Kawa S.
International Journal of Rheumatology, 2013, 272595, 2013 - Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection
Matsumoto A, Tanaka E, Morita S, Yoshizawa K, Umemura T, Joshita S
J Gastroenterol, 47(9), 1006-13, Sep. 2012 - Long-term outcome of japanese patients with type 1 autoimmune hepatitis
Yoshizawa K, Matsumoto A, Ichijo T, Umemura T, Joshita S, Komatsu M, Tanaka N, Tanaka E, Ota M, Katsuyama Y, Kiyosawa K, Abe M, Onji M
Hepatology, 56(2), 668-76, Aug. 2012 - Clinical Characteristics of Young-Onset Ischemic Colitis
Kimura T, Shinji A, Horiuchi A, Tanaka N, Nagaya T, Shigeno T, Nakamura N, Komatsu M, Umemura T, Arakura N, Matsumoto A, Tanaka E
Dig Dis Sci, 57(6), 1652-9, Jun. 2012 - 【C型肝炎-新時代の治療戦略】 新時代における各治療法の位置付けとその実際 インターフェロン療法
松本 晶博
消化器の臨床, 15(3), 266-272, Jun. 2012 - Risk factors for pancreatic stone formation in autoimmune pancreatitis over a long-term course
Maruyama M, Arakura N, Ozaki Y, Watanabe T, Ito T, Yoneda S, Muraki T, Hamano H, Matsumoto A, Kawa S
J Gastroenterol, 47(5), 553-60, May 2012 - 【B型肝炎の抗ウイルス療法の進歩と耐性】 B型慢性肝炎核酸アナログ薬治療における中止基準
松本晶博
消化器内科, 54(5), 620-626, May 2012 - 【C型肝炎治療の新たな展開】 ALTの安定化を目指した少量ペグインターフェロン・リバビリン併用療法の試み
市川 雪, 松本 晶博
消化器内科, 54(4), 493-498, Apr. 2012 - Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection
Joshita S, Umemura T, Katsuyama Y, Ichikawa Y, Kimura T, Morita S, Kamijo A, Komatsu M, Ichijo T, Matsumoto A, Yoshizawa K, Kamijo N, Ota M, Tanaka E
Hum Immunol, 73(3), 298-300, Mar. 2012 - Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
Matsumoto A, Tanaka E, Suzuki Y, Kobayashi M, Tanaka Y, Shinkai N, Hige S, Yatsuhashi H, Nagaoka S, Chayama K, Tsuge M, Yokosuka O, Imazeki F, Nishiguchi S, Saito M, Fujiwara K, Torii N, Hiramatsu N, Karino Y, Kumada H
Hepatol Res, 42(2), 139-149, Feb. 2012 - 【B型肝炎:克服へのロードマップ】 核酸アナログ療法の現状と展望 核酸アナログ中止症例の短期・長期予後 HBコア関連抗原の有用性
松本 晶博
肝・胆・膵, 65(4), 703-710, Jan. 2012 - 核酸アナログ薬中止に伴うリスク回避のための指針2012―厚生労働省「B型肝炎の核酸アナログ薬治療における治療中止基準の作成と治療中止を目指したインターフェロン治療の有用性に関する研究」の報告―
田中 榮司, 松本 晶博, 鈴木 義之, 小林 万利子, 田中 靖人, 新海 登, 髭 修平, 八橋 弘, 長岡 進矢, 茶山 一彰, 柘植 雅貴, 横須賀 收, 今関 文夫, 西口 修平, 齋藤 正紀, 藤原 圭, 鳥居 信之, 平松 直樹, 狩野 吉康
肝臓, 53(4), 237-242, 2012 - Early detection of interstitial pneumonia by monitoring KL-6 in a chronic hepatitis C patient undergoing pegylated interferon and ribavirin therapy
Ichikawa-Yamada Y, Joshita S, Tsukahara Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E
Hepatol Res, 41(9), 904-9, Sep. 2011 - B型慢性肝炎に対する核酸アナログ投与中止例の解析
松本晶博
消化器内科, 53(3), 309-315, Sep. 2011 - Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C
Yoneda S, Umemura T, Joshita S, Ichijo T, Matsumoto A, Yoshizawa K, Katsuyama Y, Ota M, Tanaka E
Hepatol Res, 41(6), 587-93, Jun. 2011 - 【肝炎・肝癌の新しい診断と治療】 (Session 1)B型肝炎 HBs抗原量測定の臨床的意義
田中榮司, 松本晶博
犬山シンポジウム, 28, 25-32, Jun. 2011 - Kidney transplantation recovers the reduction level of serum sulfatide in ESRD patients via processes correlated to oxidative stress and platelet count
Wang L, Kamijo Y, Matsumoto A, Nakajima T, Higuchi M, Kannagi R, Kyogashima M, Aoyama T, Hara A
Glycoconj J, 28(3-4), 125-35, May 2011 - 【新時代のウイルス性肝炎学 基礎・臨床研究の進歩】 B型肝炎 B型肝炎の病態 B型肝炎の発症機序と病態
田中榮司, 松本晶博, 梅村武司
日本臨床, 69, 417-421, May 2011 - Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
Chayama K, Hayes CN, Yoshioka K, Moriwaki H, Okanoue T, Sakisaka S, Takehara T, Oketani M, Toyota J, Izumi N, Hiasa Y, Matsumoto A, Nomura H, Seike M, Ueno Y, Yotsuyanagi H, Kumada H
J Gastroenterol, 46(4), 545-55, Apr. 2011 - Cytokine profiles affecting the pathogenesis of autoimmune hepatitis in Japanese patients
Kamijo A, Yoshizawa K, Joshita S, Yoneda S, Umemura T, Ichijo T, Matsumoto A, Ota M, Tanaka E
Hepatol Res, 41(4), 350-7, Apr. 2011 - Association of Serum Cytokine Levels With Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients
Yoneda S, Umemura T, Katsuyama Y, Kamijo A, Joshita S, Komatsu M, Ichijo T, Matsumoto A, Yoshizawa K, Ota M, Tanaka E
J Infect Dis, 203(8), 1087-95, Mar. 2011 - ソラフェニブの投与が有効であった、転移を伴う肝細胞癌の2症例
城下智, 上條敦, 山田雪, 木村岳史, 森田進, 梅村武司, 一條哲也, 松本晶博, 吉澤要, 田中榮司
長野県医学会雑誌, 41, 79-81, Mar. 2011 - 【ウイルス肝炎診療の変貌 近づく疾患克服】 B型肝炎 核酸アナログ治療、継続か中止か?
松本晶博
肝・胆・膵, 62(2), 243-250, Feb. 2011 - 【B型肝炎治療の最新戦略】 核酸アナログ薬治療例におけるHBs抗原量の推移とその臨床的意義
松本晶博
消化器内科, 52(1), 103-107, Jan. 2011 - Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C
Umemura T, Joshita S, Yoneda S, Katsuyama Y, Ichijo T, Matsumoto A, Yoshizawa K, Ota M, Tanaka E
Antivir Ther, 16(7), 1073-80, 2011 - A Case of Pyogenic Liver Abscess Infected with Fusobacterium necrophorum Depicted by Microscopy and Confirmed by Tissue Culture
Nozawa Y, Joshita S, Fukushima M, Sugiyama Y, Ichikawa Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E
Intern Med, 50(17), 1815-9, 2011 - 【肝胆膵薬物治療学の進歩 この30年】 肝臓分野 B型肝炎治療薬 ラミブジン(ゼフィックス)開発の歴史と意義
田中榮司, 松本晶博
肝・胆・膵, 61(6), 981-987, Dec. 2010 - Down-regulation of SREBP-1c is associated with the development of burned-out NASH
Nagaya T, Tanaka N, Suzuki T, Sano K, Horiuchi A, Komatsu M, Nakajima T, Nishizawa T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Nakayama J, Tanaka E, Aoyama T
J Hepatol, 53(4), 724-31, Oct. 2010 - Comparison of hepatitis B virus DNA, RNA, and core related antigen as predictors of lamivudine resistance in patients with chronic hepatitis B
Matsumoto A, Maki N, Yoshizawa K, Umemura T, Joshita S, Tanaka E
shinshu med J, 58(4), 153-162, Aug. 2010 - Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels
Tsutsui M, Tanaka N, Kawakubo M, Sheena Y, Horiuchi A, Komatsu M, Nagaya T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Aoyama T, Tanaka E, Sano K
J Clin Gastroenterol, 44(6), 440-7, Jul. 2010 - A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome
Joshita S, Yoshizawa K, Sano K, Kobayashi S, Sekiguchi T, Morita S, Kamijo A, Komatsu M, Umemura T, Ichijo T, Matsumoto A, Tanaka E
Intern Med, 49(11), 991-4, Jun. 2010 - Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits
Tsuruta G, Tanaka N, Hongo M, Komatsu M, Horiuchi A, Hamamoto K, Iguchi C, Nakayama Y, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Aoyama T, Tanaka E
J Gastroenterol, 45(6), 666-72, Jun. 2010 - B型肝炎に対する抗ウイルス療法
田中榮司, 松本晶博
カレントテラピー, 28(8), 20-24, 2010 - Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: some concerns (reply)
Matsumoto A, Tanaka E
Hepatology, 49(6), 2125, Jun. 2009 - 広範囲の肝実質の脱落により奇異な肝形態を呈し自己免疫性肝炎が疑われた1例
城下智, 一條哲也, 吉澤要, 福島万奈, 小松通治, 新井薫, 田中直樹, 梅村武司, 松本晶博, 田中榮司
GASTROENTEROLOGICAL ENDOSCOPY, 51, 48-54, 2009 - 透析関連事故調査報告
杉山敏, 清澤研道, 川茂幸, 樋口誠, 松本晶博, 江原孝史, 野本昭三, 透析関連事故原因究明調査委員会
日本透析医学会雑誌, 42, 473-480, 2009 - 【B型肝炎 病態解明と治療の最前線】 B型肝炎の治療最前線 HBV core関連抗原とB型肝炎治療
田中榮司, 松本晶博
臨床消化器内科, 24, 709-715, 2009 - 複数回治療後の再発性肝細胞癌の局所療法にソナゾイド造影超音波が有用であった1例
米田傑, 城下智, 一條哲也, 上條敦, 小松通治, 梅村武司, 松本晶博, 吉澤要, 田中榮司
肝臓, 50, 250-256, 2009 - 【肝癌撲滅最前線】 発生抑止 肝癌発生抑止戦略 B型肝炎
松本晶博
内科, 104, 651-655, 2009 - Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors
Shirakawa H, Matsumoto A, Joshita S, Komatsu M, Tanaka N, Umemura T, Ichijo T, Yoshizawa K, Kiyosawa K, Tanaka E
Hepatology, 48(6), 1753-60, Dec. 2008 - 【C型肝炎のすべて・2009】 合併症を有する患者のhcv治療 血小板減少例の対策 脾摘
松本晶博, 一條哲也, 田中榮司
肝・胆・膵, 57(5), 969-974, Nov. 2008 - 【肝発癌の制御】 抗hbv薬による肝発癌の制御
松本晶博, 田中榮司
細胞, 40(13), 557-560, Nov. 2008 - 【B型慢性肝炎治療の新展開】 B型慢性肝炎のadvおよびetv治療におけるhbコア関連抗原の有用性
松本晶博, 田中榮司
消化器科, 47(4), 431-436, Oct. 2008 - Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase
Tanaka N, Nagaya T, Komatsu M, Horiuchi A, Tsuruta G, Shirakawa H, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Aoyama T, Kiyosawa K, Tanaka E
Liver Int, 28(8), 1104-11, Sep. 2008 - 【核酸アナログ時代のb型肝炎治療】 核酸アナログ剤各論 ラミブジン
松本晶博, 田中榮司
肝・胆・膵, 56(5), 671-678, May 2008 - 【高齢者C型慢性肝炎に対する治療のあり方】 高齢者に対するPeg-IFNα2b/Ribavirin併用療法の効果と安全性
松本晶博, 田中榮司
消化器科, 46(4), 442-449, Apr. 2008 - 【肝疾患に対する脾摘・Pseの功罪】 Ifn療法における脾摘、Pseの功罪 Ifn療法におけるpseの功罪
松本晶博, 一條哲也, 田中榮司
肝・胆・膵, 56(3), 361-366, Mar. 2008 - 治療のピットフォール 肝炎ウイルスキャリアに対する化学療法使用時の注意点
松本晶博
治療学, 42(1), 76-80, Jan. 2008 - Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy
Tanaka E, Matsumoto A, Yoshizawa K, Maki N
INTERVIROLOGY, 51 Suppl 1, 3-6, 2008 - 腹壁への浸潤が疑われ、画像検査が診断の契機となった肝放線菌症の1例
武藤英知, 一條哲也, 小林倫子, 田中直樹, 梅村武司, 小松通治, 松本晶博, 吉澤要, 田中榮司, 上田和彦, 角谷眞澄, 清澤研道
肝臓, 48(11), 553-558, Nov. 2007 - Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy
Matsumoto A, Tanaka E, Minami M, Okanoue T, Yatsuhashi H, Nagaoka S, Suzuki F, Kobayashi M, Chayama K, Imamura M, Yotsuyanagi H, Nakaoka S, Maki N, Kawata S, Kumada H, Iino S, Kiyosawa K
Hepatol Res, 37(8), 661-6, Aug. 2007 - 【B型肝炎の最新診療】 B型肝炎の発癌抑制と長期予後向上のための対策
松本晶博, 田中榮司
消化器の臨床, 10(2), 196-201, Apr. 2007 - 【ウイルス肝炎の臨床 飛躍的に進化する最新治療を実地診療に生かすコツ】 ウイルス肝炎の臨床・治療 実地診療におけるB型肝炎の治療の実際 ラミブジン長期服用例の今後の対策 既投与例をこれからどうする?
松本晶博, 田中榮司
Medical Practice, 24(4), 691-697, Apr. 2007 - 当科における非アルコール性脂肪肝炎の現状
小松通治, 田中直樹, 小林倫子, 武藤英知, 新井薫, 梅村武司, 一條哲也, 松本晶博, 吉澤要, 田中榮司, 清澤研道
長野県医学会雑誌, 37, 15, Mar. 2007 - Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C
Umemura T, Muto H, Tanaka E, Matsumoto A, Ichijo T, Yoshizawa K, Akamatsu T, Kiyosawa K
J Viral Hepat, 14(1), 48-54, Jan. 2007 - 【B型肝炎の新たな治療展開】 B型肝炎治療モニター B型肝炎ウイルスのcore関連抗原
松本晶博, 田中榮司
内科, 100(4), 653-657, Jan. 2007 - 【ウイルス性肝炎 最新治療コンセンサス】 ラミブジン長期投与例の今後の治療 エンテカビル、アデフォビルとの使い分け
松本晶博, 田中榮司
医学のあゆみ, 223(2), 149-152, Jan. 2007 - 高感度HCV抗原測定用試薬「ARCHITECT HCV Ag」の基礎的・臨床的評価
熊田博光, 清澤研道, 小林万利子, 小山富子, 田中榮司, 中尾瑠美子, 松本晶博, 安田清美, 八橋弘, 吉澤浩司, 飯野四郎
消化器科, 45(4), 454-466, Jan. 2007
